Followers | 177 |
Posts | 24415 |
Boards Moderated | 12 |
Alias Born | 04/03/2002 |
Friday, September 27, 2019 3:53:21 PM
About CANABC Services
CANABC Services Ltd. ('CANABC') is a Canadian medical and Micro Licensing firm based in Kelowna, British Columbia. Since 2007, the company's consultants have provided medical licensing services for patients exploring cannabis as a treatment option. CANABC is expanding its services to include full-spectrum consulting to assist cannabis entrepreneurs to obtain Micro (craft) Licenses from Health Canada.
http://www.canabc.com
About Canary Rx Inc.
Canary Rx Inc. ("Canary") is in the final stages of obtaining a license to cultivate under the Cannabis Act. Situated in Ontario's Garden, Norfolk County, Canary lies nestled amongst the shores of Lake Erie in a vibrant, agricultural community. Our 44,000 sq. ft. facility is engineered to meet strict quality standards and equipped with the latest environmental control technology. The production space includes eight separate flower rooms, projected to produce 3,600kg cannabis per year. Canary's talented team will cultivate premium, organic cannabis, while aligning with distinguished, veteran brands to bring the highest quality product to market. http://www.canaryrx.com
About Target Group Inc.
Target Group Inc. ("Target Group" or the "Company") is a progressive, diversified, and vertically integrated cannabis acquisition company. Target Group is curating an iconic brand portfolio, leveraging product diversification, innovation, and operational expertise to solidify long-term growth and stability. The Company owns and operates Canary Rx Inc, a final-stage Canadian cannabis license applicant, and CannaKorp, makers of the pod-based Wisp™ Vapor technology. Target Group is expanding its global operations to build an international network of manufacturing, distribution, production, and sales operations.
http://www.targetgroupinc.ca
Recent CBDY News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 10:04:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:12:49 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 08/04/2023 09:30:29 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM